This Biotech Startup Aims To Speed Up Drug Testing On Animals forbes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbes.com Daily Mail and Mail on Sunday newspapers.
The funding, which values Abridge at $850 million, will go towards R&D efforts to help fill in the gaps of what doctors don’t say during patient exams.
The Utah-based pharmaceutical company has trained a large language model to enable scientists to tap into dozens of machine learning models at once, saving them time during drug development.
The new contest aims to spur innovation into longer ‘healthspans’ with treatments that can actually reverse age-related degradation in body, mind and immune system.